BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8562965)

  • 1. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines.
    Kruyt FA; Dijkmans LM; van den Berg TK; Joenje H
    Blood; 1996 Feb; 87(3):938-48. PubMed ID: 8562965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation.
    Kupfer GM; D'Andrea AD
    Blood; 1996 Aug; 88(3):1019-25. PubMed ID: 8704210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function.
    Heinrich MC; Hoatlin ME; Zigler AJ; Silvey KV; Bakke AC; Keeble WW; Zhi Y; Reifsteck CA; Grompe M; Brown MG; Magenis RE; Olson SB; Bagby GC
    Blood; 1998 Jan; 91(1):275-87. PubMed ID: 9414295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knock-out mouse cells.
    Otsuki T; Wang J; Demuth I; Digweed M; Liu JM
    Int J Hematol; 1998 Apr; 67(3):243-8. PubMed ID: 9650445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fanconi anemia complementation group C protein corrects DNA interstrand cross-link-specific apoptosis in HSC536N cells.
    Marathi UK; Howell SR; Ashmun RA; Brent TP
    Blood; 1996 Sep; 88(6):2298-305. PubMed ID: 8822951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.
    Carreau M; Gan OI; Liu L; Doedens M; McKerlie C; Dick JE; Buchwald M
    Blood; 1998 Apr; 91(8):2737-44. PubMed ID: 9531583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BIK (NBK) is a mediator of the sensitivity of Fanconi anaemia group C lymphoblastoid cell lines to interstrand DNA cross-linking agents.
    Prieto-Remón I; Sánchez-Carrera D; López-Duarte M; Richard C; Pipaón C
    Biochem J; 2012 Nov; 448(1):153-63. PubMed ID: 22873408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality.
    Pang Q; Christianson TA; Keeble W; Diaz J; Faulkner GR; Reifsteck C; Olson S; Bagby GC
    Blood; 2001 Sep; 98(5):1392-401. PubMed ID: 11520787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity.
    Yamashita T; Wu N; Kupfer G; Corless C; Joenje H; Grompe M; D'Andrea AD
    Blood; 1996 May; 87(10):4424-32. PubMed ID: 8639804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
    Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
    J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells.
    Rathbun RK; Faulkner GR; Ostroski MH; Christianson TA; Hughes G; Jones G; Cahn R; Maziarz R; Royle G; Keeble W; Heinrich MC; Grompe M; Tower PA; Bagby GC
    Blood; 1997 Aug; 90(3):974-85. PubMed ID: 9242526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome.
    Ridet A; Guillouf C; Duchaud E; Cundari E; Fiore M; Moustacchi E; Rosselli F
    Cancer Res; 1997 May; 57(9):1722-30. PubMed ID: 9135015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the Fanconi's anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase.
    Kruyt FA; Dijkmans LM; Arwert F; Joenje H
    Cancer Res; 1997 Jun; 57(11):2244-51. PubMed ID: 9187128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups.
    Li Y; Youssoufian H
    J Clin Invest; 1997 Dec; 100(11):2873-80. PubMed ID: 9389754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
    Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
    Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the Fanconi anemia gene FAC in human cell lines: lack of effect of oxygen tension.
    Joenje H; Youssoufian H; Kruyt FA; dos Santos CC; Wevrick R; Buchwald M
    Blood Cells Mol Dis; 1995; 21(3):182-91. PubMed ID: 8673470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
    Yamashita T; Nakahata T
    Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.
    Kupfer G; Naf D; Garcia-Higuera I; Wasik J; Cheng A; Yamashita T; Tipping A; Morgan N; Mathew CG; D'Andrea AD
    Exp Hematol; 1999 Apr; 27(4):587-93. PubMed ID: 10210316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of immortalized fibroblastoid cell lines from an FA(C) mouse model.
    Tomkins DJ; Care M; Carreau M; Buchwald M
    Mutat Res; 1998 Jul; 408(1):27-35. PubMed ID: 9678061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
    Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.